相关实验视频
Updated: Jul 17, 2025

08:50
Predictive Immune Modeling of Solid Tumors
Published on: February 25, 2020
7.0K
新辅助免疫治疗在黑色素瘤中的生物标志物驱动个性化
Lotte L Hoeijmakers1, Irene L M Reijers1, Christian U Blank1,2,3
1Department of Medical Oncology, Netherlands Cancer Institute (NKI), Amsterdam, the Netherlands.
Cancer discovery
|September 5, 2023
概括
在第三阶段黑色素瘤中新辅助免疫疗法的生物标志物发现正在推进个性化癌症治疗. 这种方法可以指导针对黑色素瘤和潜在的其他癌症的量身定制疗法,改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 翻译研究是翻译研究.
背景情况:
- 免疫疗法在治疗包括黑色素瘤在内的各种癌症方面取得了重大进展.
- 个性化医疗需要识别治疗选择的生物标志物,特别是新疗法和早期疾病阶段干预措施.
- 第三阶段黑色素瘤是新辅助免疫疗法研究的关键模型,因为它的免疫性质和可靠的结果措施.
结论:
- 第三阶段黑色素瘤新辅助免疫疗法平台对于识别预测生物标志物至关重要.
- 这项研究促进了个性化利益风险评估,以优化个人患者的治疗选择.
- 这些发现对推进其他瘤环境中的个性化医疗有意义.
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Tumor Immunotherapy
555
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
555

